DUBLIN, Feb. 27, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Drug Discovery Technologies Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Drug Discovery Technologies Market is poised to grow at a CAGR of around 12.2% over the next decade to reach approximately $160 billion by 2025.
This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.
Some of the prominent trends that the market is witnessing include growing identification of combinatorial chemistry technology, regulatory initiatives fostering demand for pharmacogenomics technology, proteomics in anticancer drug discovery and human protein microarray for various protein analysis.
Based on technology the market is categorized into pharmacogenomics, high throughput screening, genomics, bioinformatics, biochips, bioanalytical Instruments, nanotechnology, metabolomics and other technologies. Depending on the end users the market is segmented by research institutes, pharmaceutical companies, biotech companies, biopharmaceutical companies and other end users.
Depending on the Applications the market is segmented by cardiovascular diseases, cancer Parkinson's disease, central nervous system disorders and other applications.
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
Key Topics Covered:
1 Market Outline
1.2 Market Trends
1.3 Regulatory Factors
1.4 Technology Analysis
1.5 Application Analysis
1.6 End User Analysis
1.7 Strategic Benchmarking
1.8 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Growing identification of combinatorial chemistry technology
3.1.2 Regulatory initiatives fostering demand for pharmacogenomics technology
3.1.3 Proteomics in anticancer drug discovery
3.1.4 Human protein microarray for various protein analysis
3.4 Industry Attractiveness
4 Drug Discovery Technologies Market, By Technology Type
4.2 High Throughput Screening
184.108.40.206 Structural Genomics
220.127.116.11 Functional Genomics
18.104.22.168 Other Genomics technologies
22.214.171.124.1.1 Clinical Medicine
126.96.36.199.1.2 New Antibiotics
188.8.131.52 Computer-Aided Drug Design
184.108.40.206 Lab on a chip
220.127.116.11 Proteomics microarrays
18.104.22.168 DNA and Protein microarrays
4.6 Bioanalytical Instruments
22.214.171.124 Chemotherapy instruments
126.96.36.199 Mass spectrometry
188.8.131.52 Microplate readers
184.108.40.206 Nuclear magnetic resonance
220.127.116.11 Nano-mass spectroscopy
18.104.22.168 Dip-pen Nanolithography
22.214.171.124 Atomic force microscopy (AFM)
126.96.36.199 Target Identification
188.8.131.52 Target Validation
184.108.40.206 Lead Optimization
220.127.116.11 Mode of Action
18.104.22.168 Preclinical Studies
22.214.171.124 Clinical Studies
126.96.36.199 Post-Approval Studies
4.9 Other Technologies
188.8.131.52 RNAi (RNA interference)
184.108.40.206.1.1 MiRNAS (MicroRNA sequencing)
220.127.116.11.1.2 SiRNA (Small interfering RNA)
18.104.22.168.1.3 Other RNAi technologies
22.214.171.124 Combinatorial chemistry
126.96.36.199.1.1 Chemical Encoding
188.8.131.52.1.2 Positional Encoding
184.108.40.206.1.3 Electronic Encoding
220.127.116.11 Synthetic Biology
18.104.22.168.1.1 Two dimensional gel electrphoresis- 2DGE
22.214.171.124.1.2 Two-hybrid systems
126.96.36.199 Cell Based Assays
188.8.131.52 Systems Biology
184.108.40.206.1.1 Computer Modelling
220.127.116.11 Quantitative polymerase chain reaction (QPCR)
18.104.22.168 Laboratory information management systems
22.214.171.124 Protein and nucleic acid isolation
5 Drug Discovery Technologies Market, By End User
5.1 Research Institutes
5.2 Pharmaceutical Companies
5.3 Biotech Companies
5.4 Biopharmaceutical Companies
5.5 Other End Users
6 Drug Discovery Technologies Market, By Application
6.1 Cardiovascular Diseases
6.3 Parkinson's disease
6.4 Central Nervous System Disorders
6.5 Other Applications
6.5.1 Other Applications Market Forecast to 2025 (US$ MN)
7 Drug Discovery Technologies Market, By Geography
8 Key Player Activities
8.1 Acquisitions & Mergers
8.2 Agreements, Partnerships, Collaborations and Joint Ventures
8.3 Product Launch & Expansions
8.4 Other Activities
9 Leading Companies
- Affymetrix Inc.
- Tecan Group Ltd.
- Sigma-Aldrich Corp
- Shimadzu Corp
- Perkinelmer Inc.
- Thermo Fisher Scientific Inc.
- Incyte Corp
- Gyros AB
- F. Hoffmann-La Roche Ltd.
- Evotec AG
- Chembridge Corp
- Abbott Laboratories Inc.
- Celera Corp
- Caliper Life Sciences Inc.
- Bio-Rad Laboratories Inc.
- Astrazeneca Plc.
- Albany Molecular Research Inc.
- Agilent Technologies Inc.
- Charles River Laboratories International Inc.
- Life Technologies Corp
For more information about this report visit http://www.researchandmarkets.com/research/n5klng/global_drug
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets